Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 9729 - 9736 of 12086 results

Congress Passes Full Department of Homeland Security Funding Bill
March 3, 2015| Alert| Viewpoint

Lessons from the OECD Foreign Bribery Report
March 3, 2015| Blog| Viewpoint

European patents to take effect in Morocco
March 3, 2015| Blog| Viewpoint

Highlights From the FTC - DOJ Workshop Examining Health Care Competition
March 3, 2015| Blog| Viewpoint

CMS Call Letter: Pharmacy Network Implications
March 3, 2015| Blog| Viewpoint

Will Massachusetts’ New UST Regulations Be a Game Changer?
March 3, 2015| Advisory| Viewpoint

Health Care Competition Follow-up Exam: Highlights from the Second FTC/DOJ “Examining Health Care Competition” Workshop
March 2, 2015| Alert| Viewpoint

In Case You Missed It: Health Care Enforcement in 2015 Webinar
March 2, 2015| Blog| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts

Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|

Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
